TERBINAFINE HYDROCHLORIDE by Wockhardt is [see clinical pharmacology ( )] . Approved for onychomycosis of the toenail, fingernail due to dermatophytes (tinea unguium). First approved in 2007.
Drug data last refreshed 1h ago
[see Clinical Pharmacology ( )] .
SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS
Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg
Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg
Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fed Conditions
Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions
Worked on TERBINAFINE HYDROCHLORIDE at Wockhardt? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.